Early research (Phase 1)Active Not RecruitingNCT03132922What this trial is testingMAGE-A4ᶜ¹º³²T for Multi-TumorWho this might be right forUrinary Bladder CancerMelanomaHead and Neck Cancer+7 more USWM CT, LLC 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06666166What this trial is testingSHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal CancerWho this might be right forAdvanced Gastric CarcinomaAdvanced Gastroesophageal Junction AdenocarcinomaAdvanced Colorectal Cancer Yunpeng Liu 28
Testing effectiveness (Phase 2)Study completedNCT05394740What this trial is testingClinical Study of Regorafenib and Nivolumab Plus ChemotherapyWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma National Cancer Center Hospital East 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233850What this trial is testingA Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal CancersWho this might be right forGastric/Gastroesophageal Junction AdenocarcinomaMetastatic Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more Shenyang Sunshine Pharmaceutical Co., LTD. 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06454435What this trial is testingConversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric CancerWho this might be right forGastric CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Tianjin Medical University Cancer Institute and Hospital 158
Testing effectiveness (Phase 2)Looking for participantsNCT06560528What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 OverexpressionWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04555304What this trial is testingPhase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line TherapyWho this might be right forGastric CancerGastroesophageal Cancer Chengdu Kanghong Biotech Co., Ltd. 81
Large-scale testing (Phase 3)Looking for participantsNCT04447352What this trial is testingHIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)Who this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Krankenhaus Nordwest 200
Large-scale testing (Phase 3)UnknownNCT04435652What this trial is testingQL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.Who this might be right forAdvanced Gastric or Gastroesophageal Junction Adenocarcinoma Qilu Pharmaceutical Co., Ltd. 492
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)WithdrawnNCT07283848What this trial is testingZimberelimab + Domvanalimab in Gastroesophageal AdenocarcinomaWho this might be right forAdenocarcinoma StomachAdenocarcinoma Gastroesophageal Junction Massachusetts General Hospital
Not applicableUnknownNCT06277908What this trial is testingPostoperative Morbidity and Mortality After Gastric Cancer SurgeryWho this might be right forGastric CancerSiewert Type III Adenocarcinoma of Esophagogastric JunctionStomach Cancer P. Herzen Moscow Oncology Research Institute 700
Early research (Phase 1)Ended earlyNCT06299163What this trial is testingNM32-2668 in Adult Patients With Selected Advanced Solid TumorsWho this might be right forOvarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Study completedNCT01123811What this trial is testingEfficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric CancerWho this might be right forAdenocarcinoma of Stomach or Esophagogastric Junction Johannes Gutenberg University Mainz 45
Not applicableLooking for participantsNCT04290806What this trial is testingRegistry Platform Gastric/Esophageal Cancer (SAPHIR)Who this might be right forEsophageal Squamous Cell CarcinomaGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+1 more iOMEDICO AG 1,900
Not applicableStudy completedNCT03429816What this trial is testingOPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaWho this might be right forGastric NeoplasmGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma+2 more University Hospital Heidelberg 120
Early research (Phase 1)Study completedNCT06549816What this trial is testingSGN-B6A in Chinese Participants With Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more Seagen, a wholly owned subsidiary of Pfizer 6
Testing effectiveness (Phase 2)Temporarily pausedNCT06250036What this trial is testingZimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric CancerWho this might be right forLocally Advanced Gastric AdenocarcinomaMSI-H/dMMR Gastric CancerMSI-H/dMMR Gastroesophageal-junction Cancer Royal Marsden NHS Foundation Trust 50
Large-scale testing (Phase 3)Study completedNCT03221426What this trial is testingStudy of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)Who this might be right forGastric CancerGastroesophageal Junction Cancer Merck Sharp & Dohme LLC 1,007
Large-scale testing (Phase 3)Looking for participantsNCT07118527What this trial is testingA Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forPatients With Unresectable Locally Advanced or Metastatic Untreated Gastric or Gastroesophageal Junction Adenocarcinoma Suzhou Suncadia Biopharmaceuticals Co., Ltd. 600